(S (NP (ADJP (NNP EC) (VBD funded)) (NNP STriTuVaD) (NN project)) (VP (VBZ aims) (S (VP (TO to) (VP (VB test) (, ,) (PP (IN through) (NP (DT a) (NN phase) (NNP IIb) (JJ clinical) (NN trial))) (, ,) (NP (NP (CD two)) (PP (IN of) (NP (NP (DT the) (ADJP (RBS most) (JJ advanced)) (JJ therapeutic) (NNS vaccines)) (PP (IN against) (NP (NN tuberculosis)))))))))) (. .))
(S (PP (IN In) (NP (JJ parallel))) (, ,) (NP (PRP we)) (VP (VBP have) (VP (VBN extended) (NP (DT the) (NNP Universal) (NNP Immune) (NNP System) (NNP Simulator)) (S (VP (VP (TO to) (VP (VB include) (NP (NP (DT all) (JJ relevant) (NNS determinants)) (PP (IN of) (NP (JJ such) (JJ clinical) (NN trial)))))) (, ,) (VP (TO to) (VP (VB establish) (NP (PRP$ its) (JJ predictive) (NN accuracy)) (PP (IN against) (NP (NP (DT the) (JJ individual) (NNS patients)) (VP (VBN recruited) (PP (IN in) (NP (DT the) (NN trial)))))))) (, ,) (VP (TO to) (VP (VB use) (NP (PRP it)) (S (VP (TO to) (VP (VP (VB generate) (NP (JJ digital) (NNS patients))) (CC and) (VP (VBP predict) (NP (NP (PRP$ their) (NN response)) (PP (TO to) (NP (NP (DT the) (NNP HRT)) (VP (VBG being) (VP (VBN tested)))))))))))) (, ,) (CC and) (VP (TO to) (VP (VB combine) (NP (PRP them)) (PP (TO to) (NP (NP (DT the) (NNS observations)) (VP (VBN made) (PP (IN on) (NP (JJ physical) (NNS patients)))))) (S (VP (VBG using) (NP (NP (DT a) (JJ new) (ADJP (IN in) (JJ silico-augmented)) (JJ clinical) (NN trial) (NN approach)) (SBAR (WHNP (WDT that)) (S (VP (VBZ uses) (NP (DT a) (JJ Bayesian) (JJ adaptive) (NN design)))))))))))))) (. .))
(S (NP (DT This) (NN approach)) (, ,) (SBAR (WHADVP (WRB where)) (S (VP (VBN found) (S (ADJP (JJ effective)))))) (VP (MD could) (VP (ADVP (RB drastically)) (VB reduce) (NP (NP (DT the) (NN cost)) (PP (IN of) (NP (NN innovation))) (PP (IN in) (NP (NP (DT this) (JJ critical) (NN sector)) (PP (IN of) (NP (JJ public) (NN healthcare)))))))) (. .))
(S (NP (NP (CD One)) (PP (IN of) (NP (DT the) (ADJP (RBS most) (JJ challenging)) (NN task)))) (VP (VBZ is) (S (VP (TO to) (VP (VP (VB develop) (NP (NP (DT a) (NN methodology)) (SBAR (S (VP (TO to) (VP (VB reproduce) (NP (NP (JJ biological) (NN diversity)) (PP (IN of) (NP (NP (DT the) (NNS subjects)) (SBAR (WHNP (WDT that)) (S (VP (VBP have) (S (VP (TO to) (VP (VB be) (VP (VBN simulated))))))))))))))))) (, ,) (FW i.e.) (, ,) (VP (VBP provide) (NP (NP (DT an) (JJ appropriate) (NN strategy)) (PP (IN for) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (NP (NNS libraries)) (PP (IN of) (NP (JJ digital) (NNS patients))))))))))))) (. .))
(S (NP (DT This)) (VP (VBZ has) (VP (VBN been) (VP (VBN achieved) (PP (PP (IN through) (NP (NP (DT the) (DT the) (NN creation)) (PP (IN of) (NP (DT the) (JJ initial) (NN immune) (NN system) (NN repertoire))) (PP (IN in) (NP (DT a) (JJ stochastic) (NN way))))) (, ,) (CC and) (PP (IN though) (NP (NP (DT the) (NN identification)) (PP (IN of) (NP (NP (DT a) (`` ``) (NN vector)) (PP (IN of) (NP (NNS features))) ('' '') (SBAR (WHNP (WDT that)) (S (VP (VBZ combines) (NP (NP (ADJP (DT both) (JJ biological) (CC and) (JJ pathophysiological)) (NNS parameters)) (SBAR (WHNP (WDT that)) (S (VP (VBP personalize) (NP (DT the) (JJ digital) (NN patient)) (S (VP (TO to) (VP (VB reproduce) (NP (NP (NP (DT the) (NN physiology)) (CC and) (NP (DT the) (NN pathophysiology))) (PP (IN of) (NP (DT the) (NN subject)))))))))))))))))))))) (. .))
